AyurvedNews.com

Given the safety, cost-effectiveness and the success rate of Ksharasutra in the treatment of anal fistula, the Department of AYUSH, in collaboration with the ICMR and the CCRAS, is organizing a National Campaign to promote the use of Ksharasutra in ano-rectal diseases. A National Workshop is being organized on 24-25 August 2007 in the auditorium of the All India Institute of Medical Sciences, New Delhi. Eminent experts in Ksharasutra will be participating in the Workshop. In keeping with the increased interest in Ksharasutra in foreign countries, a renowned Japanese expert Dr. Kenji Tazawa will also be participating in the National Workshop.

Even though there has been a resurgence of interest in Ayurveda in India and abroad on account its proven promotive, preventive and curative aspects, one its major branches - Ayurvedic surgery- has not got much publicity. This is a bit strange considering that Ayurvedic surgery has a long and hoary tradition stretching from Susruta who lived around 1500-1000 BC.

There is one particular Ayurvedic surgical procedure described by Susruta which has been developed and standardized by Ayurvedic researchers and scientifically validated by modern medicine in the 20th century which is providing relief to large numbers of patients of Anal fistula, also known as Bhagandara in Ayurveda. The Ksharasutra procedure is a minimally invasive surgical procedure for the treatment of Anal fistula, a painful condition affecting large numbers of people which is conventionally treated by surgery. Surgery for Anal fistula requires hospitalization and postoperative care, all of which is costly, and there is probability of damage to the tissues around the anal canal. The incidence of recurrence after conventional surgery is also rather high. In comparison, Ksharasutra has much lower recurrence rate and, more importantly, is an ambulatory form of treatment and hospitalization with its attendant expenditure and loss of income is not involved. Ksharasutra is safe and can be used on patients who would otherwise be considered a high risk in conventional surgery. The cost to the patient for the procedure is also quite low.
Read the rest of this entry »

Share This

Even as China and Korea are increasing their share in the $62 billion herbal drugs market worldwide, Indian exporters of ayurvedic drugs are finding it extremely difficult to tap this high-growth segment.

There are a number of big names like Lupin, Cipla, Alkem and J B Chemicals in this area, but exports of herbal or ayurveda medicines from India stand at a tiny $0.25 billion.

Exporters have been strapped by a European Union (EU) stipulation that requires 30 years safe usage data. This effectively prevents the entry of new players from India who also face the possibility of being blacklisted for the presence of heavy metals in their medicines.

Read the remaining story at source: Business Standard

Share This

William Farley, Chairman and Owner of Farley Industries based in Chicago, IL and former CEO of Fruit of the Loom, bought his first company, Anaheim Citrus Products, in 1976. In 1977, he acquired Baumfolder, a subsidiary of Bell & Howell. Farley also became a part owner of the Chicago White Sox in 1976.

Today, Mr. Farley is about to launch a new Nutraceutical home business opportunity called Zrii; which can be viewed at ManifestCashNow.com. Bill Farley has been a friend of Dr. Deepak Chopra for many years and it all started when Dr. Deepak Chopra passed on an ancient secret on to his friend, Mr. Farley. The ancient secret found in the Zrii super tonic is Amalaki and the Chopra Center for Wellbeing wholeheartedly endorses Zrii.

Amalaki (emblica officinalis) grows at the base of the pristine Himalayan mountain range in northern India. In its pantheon of thousands of fruits and herbs, Ayurveda describes amalaki as the single most important botanical for promoting cellular rejuvenation, immune function, and increased vitality.

Simply stated, Amalaki has one of the richest and most documented legacies of any fruit known today. In fact, Amalaki has been revered as the “Nurse”, the “Great Rejuvenator”, and the “Fruit of Immortality” for centuries, due to its numerous healing properties and its ability to nourish the body on all levels. This little fruit even has its own holiday in which families share a meal under the tree, while giving thanks for the strength and luster promoted by the fruit.

Read the rest of this entry »

Share This

Rajya Sabha

The matter regarding qualified practitioners of Ayurveda, Unani, Siddha and Homoeopathy systems prescribing allopathic medicines has been examined in depth by the Hon’ble Supreme Court of India in Civil Appeal No.89 of 1987 Dr. Mukhtiar Chand & Others versus State of Punjab & Others. Representations have been received from time to time on this matter and accordingly Department of AYUSH entrusted the study of the contemporary acts on medical practice in the light of judgement of Hon’ble Supreme Court in 1987 Dr. Mukhtiar Chand & Others versus State of Punjab & Others and other similar judgements. Drugs can be sold and supplied by a Pharmacist or a Druggist only on a prescription of a Registered Medical Practitioner and who can also store them for treatment of patients.

According to Section 2 (ee) of the Drugs and Cosmetics Rules, 1995, Registered Medical Practitioner means a person -

(i) holding a qualification granted by an authority specified or notified under Section 3 of the Indian Medical Degrees Act, 1916 (7 of 1916), or specified in the Schedules to the Indian Medical Council Act, 1956 (102 of 1956); or

(ii) registered or eligible for registration in a medical register of a State meant for the registration of persons practicing the modern scientific system of medicine (excluding the Homoeopathy system of medicine); or

(iii) registered in a medical register (other than a register for the registration of Homoeopathic practitioners) of a State, who although not falling within sub-clause (i) or sub-clause (ii) is declared by a general or special order made by the State Government in this behalf as a person practicing the modern scientific system of medicine for the purposes of this Act.

Hon’ble Supreme Court upheld the validity of Rule 2 (ee) (iii) as well as the notifications issued by various State Governments thereunder allowing Ayurveda, Siddha, Unani and Homoeopathy practitioners to prescribe allopathic medicines.

In view of the above judgement, Ayurveda, Siddha, Unani and Homoeopathy practitioners can prescribe allopathic medicines under Rule 2 (ee) (iii) only in those States where they are authorized to do so by a general or special order made by the concerned State Government in that regard. Practitioners of Indian Medicine holding the degrees in integrated courses can also prescribe allopathic medicines if any State act in the State in which they are practicing recognizes their qualification as sufficient for registration in the State Medical Register.

This information was given by the Minister for Health & Family Welfare, Dr. Anbumani Ramadoss in a written reply to a question in the Rajya Sabha.

Share This